COVAXIN: News
13 Jan 2021
CoronavirusCOVAXIN shipped to eleven cities in India: Bharat Biotech
Bharat Biotech, on Wednesday, said that it has successfully air-shipped its COVID-19 vaccine COVAXIN to eleven cities in India in the early hours. It has also donated 16.5 lakh doses to the Centre.
13 Jan 2021
Indian Council of Medical Research (ICMR)Indians won't get option to choose between Covishield and COVAXIN
The government won't allow beneficiaries to choose between two coronavirus vaccines, that were granted the emergency use approval this month, Union Health Secretary Rajesh Bhushan declared on Tuesday.
10 Jan 2021
IndiaDelhi identifies 89 sites for COVID-19 vaccination drive: Health Minister
The Delhi government has identified 89 sites for the COVID-19 vaccination drive in the national capital, Health Minister Satyendar Jain said on Sunday.
09 Jan 2021
Madhya PradeshDays after participating in vaccine trial, man dies in Bhopal
A 42-year-old volunteer named Deepak Marawi, from Bhopal in Madhya Pradesh died nearly ten days after he participated in the clinical trial for COVAXIN held at a private hospital, its vice-chancellor said on Saturday.
08 Jan 2021
Oxford UniversitySevere side-effects after COVID-19 vaccine: What are your legal options?
India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).
07 Jan 2021
IndiaCOVID-19 vaccine transport to start soon; government readies plan
The central government has prepared a detailed draft for the transport of vaccines across India ahead of a nationwide roll-out.
05 Jan 2021
IndiaGlobal leaders hail India's scientific innovation to combat COVID-19
Global leaders have lauded India's leadership in scientific innovation and decisive action to combat the COVID-19 pandemic.
05 Jan 2021
Serum Institute of IndiaSII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.
04 Jan 2021
Ministry of Health and Family WelfareCOVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."
04 Jan 2021
Oxford UniversityBharat Biotech allowed COVAXIN trials on children aged 12+
Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.
03 Jan 2021
India'Finally paid off,' says Adar Poonawalla after Covishield gets approval
Serum Institute of India's (SII) chief Adar Poonawalla today wished everyone a happy new year along with a great announcement.
03 Jan 2021
Drugs Controller General of IndiaAll you need to know about vaccines approved in India
Earlier on Sunday, the Drugs Controller General of India (DCGI) announced the issuance of emergency approval to two COVID-19 vaccines for restricted use in India: Covishield and COVAXIN.
03 Jan 2021
Drugs Controller General of IndiaSII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
Two COVID-19 vaccines, Covishield and COVAXIN, have been granted emergency approval for use in India, the Drugs Controller General of India (DCGI) Dr. VG Somani said on Sunday.
03 Jan 2021
Union Health MinistryCoronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech.
31 Dec 2020
Narendra ModiCoronavirus: 'Davai bhi, kadaai bhi,' Modi calls for sustained caution
Prime Minister Narendra Modi on Thursday called for sustained caution against COVID-19, even as India looks forward to commencing its vaccination drive soon.
09 Dec 2020
Serum Institute of IndiaNo emergency approval for SII, Bharat Biotech's vaccine candidates yet
Two applications submitted by the Pune-based Serum Institute of India and Hyderabad-based Bharat Biotech seeking emergency approval for their respective COVID-19 vaccines have not been cleared, NDTV reported on Wednesday.
08 Dec 2020
Indian Council of Medical Research (ICMR)Now, Bharat Biotech seeks emergency use approval for COVAXIN
After US-based Pfizer and Pune's Serum Institute of India, Bharat Biotech has sought an emergency use approval for its coronavirus vaccine, named COVAXIN.
05 Dec 2020
IndiaHaryana minister, who received dose of coronavirus vaccine, tests positive
Haryana's Health Minister Anil Vij announced this morning that he has tested positive for coronavirus.
22 Nov 2020
Indian Council of Medical Research (ICMR)Bharat Biotech vaccine trials continued despite 'adverse event' in August
Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.
18 Nov 2020
IndiaIndia relying on five coronavirus vaccines to control pandemic
With heartening news of the coronavirus vaccine coming from different parts of the world, the Indian government is trying to understand which one would be the most feasible for the country.
08 Nov 2020
Serum Institute of IndiaVaccine tracker: Covishield trials running smoothly; COVAXIN expected by February
Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.
07 Nov 2020
VaccineCOVAXIN: Doctors, nurses, MBBS students to get first vaccine doses
Health workers will be among the first 30 crore people to be administered Bharat Biotech's COVID-19 vaccine.
01 Nov 2020
CoronavirusVaccine tracker: Covishield expected by December; Moderna readies for launch
It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.
24 Oct 2020
VaccineCoronavirus: Bharat Biotech aims to launch COVAXIN by June 2021
Hyderabad-based pharmaceutical firm Bharat Biotech is expecting to launch its coronavirus vaccine candidate, COVAXIN, by June next year.
12 Sep 2020
CoronavirusCOVAXIN animal trials confirmed to be successful: Details here
In a major development, Bharat Biotech has announced that its homegrown COVID-19 vaccine candidate - COVAXIN - has proven successful in animal trials.
22 Aug 2020
All India Institute Of Medical Sciences (AIIMS)Bharat Biotech gets approval to test COVAXIN administration through skin
Hyderabad-based Bharat Biotech has been allowed to conduct a trial to test administer its COVID-19 vaccine candidate through the skin (intradermal vaccine delivery).
14 Aug 2020
All India Institute Of Medical Sciences (AIIMS)COVAXIN: India's COVID-19 vaccine found safe in early trial
COVAXIN, the first indigenously developed COVID-19 vaccine from India, has proven to be safe in early human trials.
05 Aug 2020
Zydus CadilaZydus Cadila's COVID-19 vaccine found safe, going into Phase-2 trial
Indian drug company Zydus Cadila has completed early-stage human trials with its indigenously developed COVID-19 vaccine.
04 Aug 2020
VaccineCOVAXIN will cost less than water bottle: Bharat Biotech MD
Ever since companies started developing vaccines for COVID-19, one big question has been on everyone's mind: how much the final, approved shot would cost to the public?
04 Aug 2020
All India Institute Of Medical Sciences (AIIMS)AIIMS vaccine trials: 80% volunteers found unfit for study
Nearly two weeks ago, AIIMS Delhi had started the Phase 1 human trial of COVAXIN — the first candidate vaccine developed indigenously in India to fight the spread of COVID-19.
26 Jul 2020
VaccineCOVAXIN: First part of phase 1 trials complete; results encouraging
The first part of phase I trials of India's first indigenous COVID-19 vaccine candidate has completed and the results are said to be encouraging.
24 Jul 2020
All India Institute Of Medical Sciences (AIIMS)AIIMS Delhi starts human trials of India's first COVID-19 vaccine
The All India Institute of Medical Science (AIIMS) in Delhi has started human trials of COVAXIN, the country's first indigenously developed vaccine to prevent the novel coronavirus disease COVID-19.
19 Jul 2020
All India Institute Of Medical Sciences (AIIMS)You can enroll for AIIMS's COVID-19 vaccine trials: Here's how
India's indigenous COVID-19 vaccine candidate, COVAXIN, is set to go into human trials at AIIMS Delhi.
19 Jul 2020
Indian Council of Medical Research (ICMR)Coronavirus: 38,900+ cases in 24 hours; community spread feared
India has reported 38,902 fresh coronavirus cases in the last 24 hours, its highest single-day spike thus far. The national tally now stands at 10,77,618 cases.
17 Jul 2020
VaccineIndia's COVID-19 vaccines: What are the latest updates?
In the race to develop a vaccine for the novel coronavirus disease (COVID-19), two pharma companies are leading the way from India - Bharat Biotech and Zydus Cadila.
07 Jul 2020
Indian Council of Medical Research (ICMR)Expert panel sets conditions, ICMR's COVAXIN August-15 target looks unachievable
On July 2, the Indian Council of Medical Research (ICMR) revealed its plans to launch COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech and ICMR, by August 15.
04 Jul 2020
VaccineFollowing globally-accepted norms, says ICMR over August 15 vaccine target
The Indian Council of Medical Research (ICMR) on Saturday said that it is acting in accordance with globally-accepted norms by setting a mid-August target for developing a COVID-19 vaccine.
03 Jul 2020
Drugs Controller General of IndiaIndia's second COVID-19 vaccine cleared for human trials: Details here
India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.
03 Jul 2020
Indian Council of Medical Research (ICMR)India targets to launch first COVID-19 vaccine by August 15
In a major development, the Indian Council of Medical Research (ICMR) has announced its plan to launch a COVID-19 vaccine for public use by August 15.
30 Jun 2020
South KoreaCoronavirus, that killed over 500,000, isn't even nearing end: WHO
It has wreaked havoc on countries, destroyed economies, stripped thousands of their livelihoods, and pushed millions to poverty, but the coronavirus pandemic is still not nearing its end, WHO Chief Tedros Adhanom Ghebreyesus said in a briefing on Monday.
